NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc. filed a Form 10-Q with the Securities and Exchange Commission on May 15, 2019, under the ticker BRPA, originally the listing symbol for Big Rock Partners Acquisition Corp, a blank-check company sponsored by Big Rock Partners. The SPAC completed its initial public offering in 2017 with a stated focus on the healthcare and biopharmaceutical sector. By the time of this quarterly filing, the entity was operating under the NRX Pharmaceuticals name, indicative of a business combination with a clinical-stage biopharmaceutical developer targeting neurological and psychiatric conditions. For complete SPAC profiles, sponsor data, and filing analytics on BRPA and thousands of other vehicles, sign up at SpacDesk.